“Safety is primary focus for all our vaccines”: Covaxin-developer Bharat Biotech amid reports on AstraZeneca vaccine
Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a “single-minded focus on safety first.” Read further on Dynamite News:
English
